Edward F. McKone

Also affiliated with St. Vincent's University Hospital

MedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes”.

Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes

New England Journal of Medicine(2021)10.1056/nejmoa2100665

N/A

7.1DataRank · unranked

277 citations

Marcus Mall, Antonio Álvarez, Carla Colombo, Karin M. de Winter‐de Groot, Isabelle Fajac +17 more

Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(24)00411-9

N/A

1.9DataRank · unranked

95 citations

Lael M. Yonker, F. Vermeulen, Dario Prais, Rachel W. Linnemann, Aaron Trimble +92 more

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(22)00504-5

N/A

1.5DataRank · unranked

67 citations

Gordon MacGregor, Pilar Azevedo, V. Indihar, Claire Keating, Marcus Mall +77 more

Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(24)00407-7

N/A

1.4DataRank · unranked

50 citations

Ajay S. Kasi, Jessica E. Pittman, Renée Jensen, L. Thia, Philip Robinson +44 more

A Population-level Strain Genotyping Method to Study Pathogen Strain Dynamics in Human Infections

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.02.450905

N/A

0DataRank · unranked

1 citations

S. Durfey, Sumedha Ravishankar, Peter Jorth, Wendy Ni, Duncan Skerrett +6 more

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00297-7

N/A

0DataRank · unranked

33 citations

John P. Clancy, Raksha Jain, Scott H. Donaldson, Isabelle Fajac, Christopher H. Goss +21 more

A population-level strain genotyping method to study pathogen strain dynamics in human infections

JCI Insight(2021)10.1172/jci.insight.152472

N/A

0DataRank · unranked

6 citations

S. Durfey, Sumedha Ravishankar, Peter Jorth, Wendy Ni, Duncan Skerrett +6 more